Effect of nicorandil, on blood glucose level in alloxan induced diabetic rats and its pharmacodynamic interaction with glibenclamide
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20184850Keywords:
Alloxan, Glibenclamide, Nicorandil, SulfonylureasAbstract
Background: Diabetes increases the risk of macrovascular complications and is often associated with angina in patient. Currently nicorandil, a potassium channel opener is being frequently used for the prevention and long-term treatment of angina pectoris. Glibenclamide exerts its antidiabetic action by closing the ATP sensitive potassium channels. Simultaneous use of nicorandil may antagonizes this action and may worsens the existing diabetes. To evaluate the pharmacodynamic interaction present study has been taken to study the effect of Nicorandil, a potassium channel opener on blood glucose level of alloxan induced diabetic rats and its pharmacodynamics interaction with Glibenclamide.
Methods: Albino rats, weighing 150-200gm of male sex were used for the study. Diabetes was induced by injecting alloxan monohydrate 2% solution intra peritoneally in a dose of 150mg/kg body weight. Animal with Fasting Blood Sugar level between 250-300g/dl was selected for study and they were divided into 4 groups of 5 animals each. Group I- serving as control received 0.5ml normal saline orally for 28 days. Group II was given glibenclamide (0.5mg/kg body wt) for 28 days. Group III was treated orally with nicorandil (0.3mg/kg body wt) for 28 days. Group IV was given glibenclamide (0.5mg/kg) and nicorandil (0.3mg/kg) for 28 days. Fasting Blood Sugar level was recorded in all rats on 1st,3rd,7th,14th,21st and 28th day of the treatments.
Results: results showed that glibenclamide significantly reduce blood sugar level (p <0.05) Wherase nicorandil showed rise in blood glucose level (p <0.05) While the combination (glibenclamide + nicorandil) showed rise in blood glucose (p <0.05) overall.
Conclusions: Nicorandil worsen the existing diabetes and to be avoided or replaced with alternative drug in case of diabetes being treated with sulfonyl urease group of drugs.
Metrics
References
IDF. Diabetes Atlas, 8th ed. Available at: http://www.idf.org/idf-diabetes-atlas-seventh-edition2015 accessed on 20/9/2016.
Kaveeshwar SA, Cornwall J. The current state of diabetes mellitus in India. Australasian Med J. 2014;7(1):45-8.
Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004 May 1;27(5):1047-53.
Enas EA, Mehta J. Malignant coronary artery disease in young Asian Indians: thoughts on pathogenesis, prevention, and therapy. Clinical Cardiol. 1995 Mar;18(3):131-5.
National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular diseases and Stroke (NPCDCS). Operational Guidelines. Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India. 2011. Available at: http://health.bih.nic.in/Docs/ Guidelines/Guidelines NPCDCS.pdf.
Mannhold R. KATP channel openers: Structure‐activity relationships and therapeutic potential. Medicinal Res Rev. 2004 Mar;24(2):213-66.
Zhuo ML, Huang Y, Liu DP, Liang CC. KATP channel: relation with cell metabolism and role in the cardiovascular system. Int J Biochem Cell Biol. 2005 Apr 1;37(4):751-64.
Sandhiya S, Dkhar SA. Potassium channels in health, disease & development of channel modulators. Indian J Med Res. 2009 Mar 1;129(3):223.
Ahmed SM. Study of influence of nicorandil on hypoglycemic action of glibenclamide in alloxan induced diabetic rats. Int J Basic Clin Pharmacol. 2016;5(5):2146-52.
Meraj T, Khatoon M, Reddy NAR. Influence of fluoxetine on pharmacokinetics and pharmacodynamics of glibenclamide in diabetic rats. Asian J Pharm Clin Res. 2014;7(2):76-9.
Suresha RN, Mohammed S, Jayanthi MK, Kalabharathi HL, Satish AM, Pushpa VH, et al. Effect of nicorandil on basal glucose levels and after glucose challenge in normal euglycemic albino wistar rats. Int J Pharmacy Pharmaceuti Sci. 2014;(6):723-5.
Kasono K, Yasu T, Kakehashi A, Kinoshita N, Tamemoto H, Namai K, et al. Nicorandil improves diabetes and rat islet beta-cell damage induced by streptozotocin in vivo and in vitro. Eur J Endocrinol. 2004 Aug 1;151(2):277-85.
